Chronic lithium chloride administration to unanesthetized rats attenuates brain dopamine D2-like receptor-initiated signaling via arachidonic acid

Neuropsychopharmacology

Volumn 30, Issue 6, 2005, Pages 1064-1075

  Basselin, Mireille ^a   Chang, Lisa ^a   Bell, Jane M ^a   Rapoport, Stanley I ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Arachidonic acid; Bipolar disorder; Dopamine; Lithium; Phospholipase A2; Quinpirole

Indexed keywords

ARACHIDONIC ACID; DOPAMINE 2 RECEPTOR; LITHIUM CHLORIDE; PHOSPHOLIPASE A2; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BEHAVIORAL SCIENCE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; DRUG BLOOD LEVEL; DRUG BRAIN LEVEL; DRUG EFFECT; FEEDING; FRONTAL CORTEX; ISOTOPE LABELING; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PUTAMEN; RADIOACTIVITY; RAT; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ANIMALS; ANTIMANIC AGENTS; ARACHIDONIC ACID; AUTORADIOGRAPHY; BRAIN CHEMISTRY; DIET; DOPAMINE AGONISTS; LITHIUM CHLORIDE; MALE; PHOSPHOLIPASES A; QUINPIROLE; RATS; RATS, INBRED F344; RECEPTORS, DOPAMINE D2; SIGNAL TRANSDUCTION; STEREOTYPED BEHAVIOR; WEIGHT GAIN;

EID: 19344366581     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1300671     Document Type: Article

References (145)

1. 4 dopamine receptor protein in the CNS using anti-receptor antisera. Brain Res 752: 26-34.
2. Arnt J, Hyttel J, Perregaard J (1987). Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. Eur J Pharmacol 133: 137-145.
3. 2 and G proteins. Trends Neurosci 18: 64-65.
4. Bach NJ, Kornfeld EC, Jones ND, Chaney MO, Dorman DE, Paschal JW et al (1980). Bicyclic and tricyclic ergoline partial structures. Rigid 3-(2-aminoethyl)pyrroles and 3- and 4-(2-aminoethyl)pyrazoles as dopamine agonists. J Med Chem 23: 481-491.
5. Barchas JD, Hamblin MW, Malenka RC (1994). Biochemical hypotheses of mood and anxiety disorders. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds). Basic Neurochemistry, 5th edn. Raven Press: New York. pp 979-1001.
6. 2. Biochem Pharmacol 55: 515-521.
7. Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI (2003a). Chronic lithium administration increases cholinergic and decreases dopaminergic-agonist induced signal transduction via arachidonic acid in awake rats. Soc Neurosci Abstr 33: 799.1.
8. Basselin M, Chang L, Seemann R, Bell JM, Rapoport SI (2003b). Chronic lithium administration potentiates brain arachidonic acid signaling at rest and during cholinergic activation in awake rats. J Neurochem 85: 1553-1562.
9. 2A/2C receptor-mediated brain signaling via arachidonic acid. Neuropsychopharmacology 30: 461-472.
10. Baxter Jr LR, Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE et al (1985). Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry 42: 441-447.
11. 2 is coupled to muscarinic receptors in the human astrocytoma cell line 1321N1: characterization of the transducing mechanism. Biochem J 323: 281-287.
12. Bhana N, Perry CM (2001). Olanzapine: a review of its use in the treatment of bipolar I disorder. CNS Drugs 15: 871-904.
13. Bliss EL, Ailion J (1970). The effect of lithium upon brain neuroamines. Brain Res 24: 305-310.
14. 2 dopamine agonists in intact rats. Brain Res 504: 276-283.
15. 2 concentration in rat brain. Mol Psychiatry 202: 844-849.
16. Bosetti F, Seemann R, Bell JM, Zahorchak R, Friedman E, Rapoport SI et al (2002b). Analysis of gene expression with cDNA microarrays in rat brain after 7 and 42 days of oral lithium administration. Brain Res Bull 57: 205-209.
17. 2 receptor binding sites in brain samples from depressed suicides and controls. Brain Res 752: 227-233.
18. 2 autoreceptors. Neuropharmacology 37: 793-802.
19. Brodal A (1981). Neurological Anatomy in Relation to Clinical Medicine 3rd edn. Oxford University Press: Oxford.
20. Brooks DJ, Torjanski N, Burn DJ (1995). Ropinirole in the symptomatic treatment of Parkinson's disease. J Neural Transm Suppl 45: 231-238.
21. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS (1979). Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205: 929-932.
22. Bunney WEJ, Garland-Bunney BL (1987). Mechanisms of action of lithium in affective illness: basic and clinical implications. In: Meltzer HY (ed). Psychopharmacology: The Third Generation of Progress. Raven: New York, pp 553-565.
23. Bymaster FP, Calligaro DO, Falcone JF (1999). Arachidonic acid release in cell lines transfected with muscarinic receptors: a simple functional assay to determine response of agonists. Cell Signal 11: 405-413.
24. Bymaster FP, Carter PA, Yamada M, Gomeza J, Wess J, Hamilton SE et al (2003). Role of specific muscarinic receptor subtypes in cholinergic parasympathomimetic responses, in vivo phosphoinositide hydrolysis, and pilocarpine-induced seizure activity. Eur J Neurosci 17: 1403-1410.
25. Bymaster FP, Felder CC (2002). Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents. Mol Psychiatry 7(Suppl 1): S57-S63.
26. Cade JF (1999). John Frederick Joseph Cade: family memories on the occasion of the 50th anniversary of his discovery of the use of lithium in mania. 1949. Aust N Z J Psychiatry 33: 615-622.
27. Carli M, Anand-Srivastava MB, Molina-Holgado E, Dewar KM, Reader TA (1994). Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem Int 24: 13-22.
28. Carpenter TL, Pazdernik TL, Levant B (2003). Differences in quinpirole-induced local cerebral glucose utilization between naive and sensitized rats. Brain Res 964: 295-301.
29. Carvey PM, Kao LC, Zhang TJ, Amdur RL, Lin DH, Singh R et al (1990). Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav 35: 291-300.
30. Casebolt TL, Jope RS (1989). Long-term lithium treatment selectively reduces receptor-coupled inositol phospholipid hydrolysis in rat brain. Biol Psychiatry 25: 329-340.
31. 11C]-arachidonate in normocapnic and hypercapnic monkeys, measured with positron emission tomography. Brain Res 755: 74-83.
32. Chang MCJ, Grange E, Rabin O, Bell JM, Allen DD, Rapoport SI (1996). Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci Lett 220: 171-174.
33. Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK (1999). Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosom Med 61: 599-617.
34. Colin SF, Chang HC, Mollner S, Pfeuffer T, Reed RR, Duman RS et al (1991). Chronic lithium regulates expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proc Natl Acad Sci USA 88: 10634-10637.
35. Cooper JR, Bloom FE, Roth RH (1996). The Biochemical Basis of Neuropharmacology 7th edn. Oxford University Press: Oxford.
36. Cory-Slechta DA, Zuch CL, Fox RA (1996). Comparison of the stimulus properties of a pre- vs a putative postsynaptic dose of quinpirole. Pharmacol Biochem Behav 55: 423-432.
37. Dalen P, Steg G (1973). Lithium and levodopa in parkinsonism. Lancet 1: 936-937.
38. 4 dopamine receptor in rat brain with sequence-specific antibodies. Brain Res Mol Brain Res 45: 1-12.
39. DeGeorge JJ, Nariai T, Yamazaki S, Williams WM, Rapoport SI (1991). Arecoline-stimulated brain incorporation of intravenously administered fatty acids in unanesthetized rats. J Neurochem 56: 352-355.
40. 14C]arachidonate to examine regional brain lipid metabolism in unanesthetized rats. J Neurosci Res 24: 413-423.
41. 2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 39: 59-67.
42. DeMar JC, Ma K, Bell J, Rapoport SI (2004). Brain conversion of linoleic to arachidonic acid is not a major source of the arachidonate found in brain phospholipids of adult rats. Abstr International Workshop on Brain Uptake and Utilization of Fatty Acids, Lipids & Lipoproteins Bethesda, MD. October 7-9.
43. 2. J Biol Chem 269: 13057-13060.
44. 2 receptor by protein kinase C. J Neurosci 13: 4846-4853.
45. Drevets WC, Price JL, Simpson Jr JR, Todd RD, Reich T, Vannier M et al (1997). Subgenual prefrontal cortex abnormalities in mood disorders. Nature 386: 824-827.
46. Dwivedi Y, Pandey GN (1997). Effects of subchronic administration of antidepressants and anxiolytics on levels of the alpha subunits of G proteins in the rat brain. J Neural Transm 104: 747-760.
47. 2 receptor mRNA in the rat striatum and nucleus accumbens. Acta Neurobiol Exp (Wars) 56: 29-34.
48. 2 receptor SPECT before and after antidepressant therapy. Psychopharmacology (Berlin) 126: 91-94.
49. 2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161: 151-157.
50. Engber TM, Susel Z, Kuo S, Chase TN (1990). Chronic levodopa treatment alters basal and dopamine agonist-stimulated cerebral glucose utilization. J Neurosci 10: 3889-3895.
51. Engel J, Berggren U (1980). Effects of lithium on behaviour and central monoamines. Acta Psychiatr Scand Suppl 280: 133-143.
52. 11C]Arachidonic acid PET activation experiments in human subjects: a feasibility study using visual stimulation. J Cereb Blood Flow Metab 23(Suppl 1): 711.
53. Evans MS, Zorumski CF, Clifford DB (1990). Lithium enhances neuronal muscarinic excitation by presynaptic facilitation. Neuroscience 38: 457-468.
54. Fadda F, Serra G, Argiolas A, Melis MR, Gessa GL (1980). Effect of lithium on 3, 4-dihydroxyphenylacetic acid (DOPAC) concentrations in different brain areas of rats. Pharmacol Res Commun 12: 689-693.
55. 2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc Natl Acad Sci USA 87: 2187-2191.
56. Fenwick PB, Robertson R (1983). Changes in the visual evoked potential to pattern reversal with lithium medication. Electro-encephalogr Clin Neurophysiol 55: 538-545.
57. Fisher G, Pelonero AL, Ferguson C (1991). Mania precipitated by prednisone and bromocriptine. Gen Hosp Psychiatry 13: 345-346.
58. Fitzpatrick F, Soberman R (2001). Regulated formation of eicosanoids. J Clin Invest 107: 1347-1351.
59. Folch J, Lees M, Sloane Stanley GH (1957). A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509.
60. Friedman E, Gershon S (1973). Effect of lithium on brain dopamine. Nature 243: 511-520.
61. Gallager DW, Pert A, Bunney Jr WE (1978). Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature 273: 309-312.
62. 3H]quinpirole binding sites in the rat brain. Synapse 14: 113-120.
63. 1-containing neurons. J Neurosci 15: 8167-8176.
64. Ghadirian AM, Annable L, Belanger MC, Chouinard G (1996). A cross-sectional study of parkinsonism and tardive dyskinesia in lithium-treated affective disordered patients. J Clin Psychiatry 57: 22-28.
65. 11C]arachidonic acid in young healthy humans measured with positron emission tomography. J Cereb Blood Flow Metab 22: 1453-1462.
66. Goodnick PJ, Meltzer HY (1984). Treatment of schizoaffective disorders. Schizophr Bull 10: 30-48.
67. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA et al (2001). Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105: 145-151.
68. Hamilton SE, Loose MD, Qi M, Levey AI, Hille B, McKnight GS et al (1997). Disruption of the m1 receptor gene ablates muscarinic receptor-dependent M current regulation and seizure activity in mice. Proc Natl Acad Sci USA 94: 13311-13316.
69. 2-mediated neurotransmitter signal transduction, in a rodent model of Parkinson's disease. J Pharmacol Exp Ther 296: 1074-1084.
70. Hegerl U, Herrmann WM, Ulrich G, Muller-Oerlinghausen B (1990). Effects of lithium on auditory evoked potentials in healthy subjects. Biol Psychiatry 27: 555-560.
71. Hesketh JE, Nicolaou NM, Arbuthnott GW, Wright AK (1978). The effect of chronic lithium administration on dopamine metabolism in rat striatum. Psychopharmacology (Berlin) 56: 163-166.
72. Ho AK, Loh HH, Craves F, Hitzemann RJ, Gershon S (1970). The effect of prolonged lithium treatment on the synthesis rate and turnover of monoamines in brain regions of rats. Eur J Pharmacol 10: 72-78.
73. Holman RT (1986). Control of polyunsaturated acids in tissue lipids. J Am Coll Nutr 5: 183-211.
74. 2 family agonist quinpirole on spontaneous behavior in the rat: dissociation between sniffing and locomotion. Psychopharmacology (Berlin) 154: 350-355.
75. Jakobsen SN, Wiborg O (1998). Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain. Brain Res 780: 46-55.
76. Janowsky DS, Overstreet DH (1995). The role of acetylcholine mechanisms in mood disorders. In: Bloom FE, Kupfer DJ (eds). Psychopharmacology. The Fourth Generation of Progress. Raven: New York. pp 945-956.
77. 3H]arachidonic acid from blood into rat brain synaptosomal fractions before and after cholinergic stimulation. J Neurochem 67: 822-829.
78. Jope RS (1993). Lithium selectively potentiates cholinergic activity in rat brain. Prog Brain Res 98: 317-322.
79. Jung H, Reme C (1994). Light-evoked arachidonic acid release in the retina: illuminance/duration dependence and the effects of quinacrine, mellitin and lithium. Light-evoked arachidonic acid release. Graefes Arch, Clin Exp Ophthalmol 232: 167-175.
80. Katzenschlager R, Sampaio C, Costa J, Lees A (2003). Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database System Rev CD003735.
81. Ketter TA, Kimbrell TA, George MS, Dunn RT, Speer AM, Benson BE et al (2001). Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder. Biol Psychiatry 49: 97-109.
82. Koene P, Prinssen EP, Cools AR (1993). Involvement of the nucleus accumbens in oral behaviour in the freely moving rat. Eur J Pharmacol 233: 151-156.
83. Lawler CP, Gilmore JH, Watts VJ, Walker QD, Southerland SB, Cook LL et al (1995). Interhemispheric modulation of dopamine receptor interactions in unilateral 6-OHDA rodent model. Synapse 21: 299-311.
84. Lee H, Villacreses NE, Rapoport SI, Rosenberger TA (2004). In vivo imaging of increased brain arachidonic acid metabolism in a lipopolysaccharide rat model of neuroinflammation. J Neurochem 91: 936-945.
85. Lerer B (1985). Studies on the role of brain cholinergic systems in the therapeutic mechanisms and adverse effects of ECT and lithium. Biol Psychiatry 20: 20-40.
86. 3H]quinpirole: identification of a discrete population of putative D3 receptors. Synapse 14: 90-95.
87. 2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90: 8861-8865.
88. LeWitt PA, Nyholm D (2004). New developments in levodopa therapy. Neurology 62: S9-S16.
89. Li PP, Tam YK, Young LT, Warsh JJ (1991). Lithium decreases Gs, Gi-1 and Gi-2 alpha-subunit mRNA levels in rat cortex. Eur J Pharmacol 206: 165-166.
90. Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA (1994). Fatty acid composition of brain, retina, and erythrocytes in breast- and formula-fed infants. Am J Clin Nutr 60: 189-194.
91. 3 receptors: effects of ions and guanine nucleotides. J Pharmacol Exp Ther 274: 790-797.
92. 2 receptor polymorphism with bipolar affective disorder in a European Multicenter Association Study of affective disorders. Am J Med Genet 114: 177-185.
93. Matsumura M, Kojima J, Gardiner TW, Hikosaka O (1992). Visual and oculomotor functions of monkey subthalamic nucleus. J Neurophysiol 67: 1615-1632.
94. Morrisett RA, Jope RS, Snead III OC (1987). Effects of drugs on the initiation and maintenance of status epilepticus induced by administration of pilocarpine to lithium-pretreated rats. Exp Neurol 97: 193-200.
95. 4 receptors in GABAergic neurons of the primate brain. Nature 381: 245-248.
96. 2+-mobilizing agent. Br J Pharmacol 124: 1651-1658.
97. 2 in the normal rat brain. J Hirnforsch 39: 391-400.
98. Ormandy GC, Song L, Jope RS (1991). Analysis of the convulsant- potentiating effects of lithium in rats. Exp Neurol 111: 356-361.
99. Pardue S, Rapoport SI, Bosetti F (2003). Co-localization of cytosolic phospholipase A(2) and cyclooxygenase-2 in Rhesus monkey cerebellum. Brain Res Mol Brain Res 116: 106-114.
100. Paxinos G, Watson C (1987). The Rat Brain in Stereotaxic Coordinates 3rd edn. Academic Press: New York.
101. 2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder. Arch Gen Psychiatry 52: 471-477.
102. Peet M, Peters S (1995). Drug-induced mania. Drug Saf 12: 146-153.
103. Pert A, Rosenblatt JE, Sivit C, Pert CB, Bunney Jr WE (1978). Long-term treatment with lithium prevents the development of dopamine receptor supersensitivity. Science 201: 171-173.
104. Pfeilschifter J, Reme C, Dietrich C (1988). Light-induced phosphoinositide degradation and light-induced structural alterations in the rat retina are enhanced after chronic lithium treatment. Biochem Biophys Res Commun 156: 1111-1119.
105. Pittman KJ, Jakubovic A, Fibiger HC (1984). The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology (Berlin) 82: 371-377.
106. Post RM, Jimerson DC, Bunney Jr WE, Goodwin FK (1980). Dopamine and mania: behavioral and biochemical effects of the dopamine receptor blocker pimozide. Psychopharmacology (Berlin) 67: 297-305.
107. Potash JB, Willour VL, Chiu YF, Simpson SG, MacKinnon DF, Pearlson GD et al (2001). The familial aggregation of psychotic symptoms in bipolar disorder pedigrees. Am J Psychiatry 158: 1258-1264.
108. 2A/2C agonist (±)2, 5-dimethoxy-4-iodophenyl-2-aminopropane (DOI). Neuropsychopharmacology 28: 244-252.
109. Rapoport SI (2001). In vivo fatty acid incorporation into brain phospholipids in relation to plasma availability, signal transduction and membrane remodeling. J Mol Neurosci 16: 243-261.
110. Rapoport SI (2003). In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism. J Pediatr 143: S26-S34.
111. Reches A, Ebstein RP, Belmaker RH (1978). The differential effect of lithium on noradrenaline- and dopamine-sensitive accumulation of cyclic AMP in guinea pig brain. Psychopharmacology (Berlin) 58: 213-216.
112. Reches A, Wagner HR, Jackson V, Fahn S (1982). Chronic lithium administration has no effect on haloperidol-induced supersensitivity of pre- and postsynaptic dopamine receptors in rat brain. Brain Res 246: 172-177.
113. Reus B, Lorenzen A, Unsicker K (2001). Dopamine and epinephrine, but not serotonin, downregulate dopamine sensitivity in cultured cortical and striatal astroglial cells. Receptors Channels 7: 441-451.
114. 2 is a target for chronic lithium in rat brain. Neuroreport 10: 3887-3890.
115. Robinson PJ, Noronha J, DeGeorge JJ, Freed LM, Nariai T, Rapoport SI (1992). A quantitative method for measuring regional in vivo fatty-acid incorporation into and turnover within brain phospholipids: review and critical analysis. Brain Res Rev 17: 187-214.
116. Rondot P, Bathien N (1979). Abnormal movements induced by psychotropic drugs. Encephale 5: 41-48.
117. Rosenberger TA, Villacreses NE, Hovda JT, Bosetti F, Weerasinghe G, Wine RN et al (2004). Rat brain arachidonic acid metabolism is increased by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide. J Neurochem 88: 1168-1178.
118. Roth BL, Willins DL, Kristiansen K, Kroeze WK (1998). 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C) where structure meets function. Pharmacol Ther 79: 231-257.
119. Sansone ME, Ziegler DK (1985). Lithium toxicity: a review of neurologic complications. Clin Neuropharmacol 8: 242-248.
120. Seeman P, Van Tol HH (1994). Dopamine receptor pharmacology. Trends Pharmacol Sci 15: 264-270.
121. Senogles SE (2000). The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 58: 455-462.
122. 3 dopamine receptor in cellular and organismal function. Psychopharmacology (Berlin) 135: 1-16.
123. Shimizu T, Wolfe LS (1990). Arachidonic acid cascade and signal transduction. J Neurochem 55: 1-15.
124. Sidhu A, Niznik HB (2000). Coupling of dopamine receptor subtypes to multiple and diverse G proteins. Int J Dev Neurosci 18: 669-677.
125. Sokoloff L (1999). Energetics of functional activation in neural tissues. Neurochem Res 24: 321-329.
126. Song L, Jope RS (1992). Chronic lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem 58: 2200-2206.
127. Sovner R, DiMascio A (1978). Extrapyramidal syndromes and other neurological side effects of psychotropic drugs. In: Lipton MA, DiMascio A, Killam KF (eds). Psychopharmacology: A Generation of Progress. Raven Press: New York. pp 1021-1032.
128. Staunton DA, Magistretti PJ, Shoemaker WJ, Bloom FE (1982a). Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity. Brain Res 232: 391-400.
129. Staunton DA, Magistretti PJ, Shoemaker WJ, Deyo SN, Bloom FE (1982b). Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity. Brain Res 232: 401-412.
130. 2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3: 51-63.
131. 2+. Br J Pharmacol 139: 1014-1022.
132. Sultzer DL, Cummings JL (1989). Drug-induced mania - causative agents, clinical characteristics and management. A retrospective analysis of the literature. Med Toxicol Adverse Drug Exp 4: 127-143.
133. Tu B, Bazan NG (2003). Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp Neurol 179: 167-175.
134. Ulrich G, Herrmann WM, Hegerl U, Muller-Oerlinghausen B (1990). Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects. J Affect Disord 20: 19-25.
135. 2. J Neurochem 64: 2765-2772.
136. 2 receptors in rat medial prefrontal cortex. Synapse 19: 112-120.
137. 3H]spiperone binding in the brain of rats. Neurochem Res 8: 637-648.
138. Wang HY, Friedman E (1999). Effects of lithium on receptor-mediated activation of G proteins in rat brain cortical membranes. Neuropharmacology 38: 403-414.
139. 4 receptors in the rat brain - immunocytochemical study. J Physiol Pharmacol 51: 205-221.
140. 2 or lipoxygenase/cytochrome P450 pathways. Brain Res Bull 63: 485-489.
141. 2+ and mitogen-activated protein kinase regulation. J Biol Chem 269: 1889-1895.
142. 2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17: 331-342.
143. 2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17: 331-342.
144. Yatham LN, Liddle PF, Lam RW, Shiah IS, Lane C, Stoessl AJ et al (2002). PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania. Am J Psychiatry 159: 1718-1723.
145. Zhou L, Vessby B, Nilsson A (2002). Quantitative role of plasma free fatty acids in the supply of arachidonic acid to extrahepatic tissues in rats. J Nutr 132: 2626-2631.